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A
 
BSTRACT
 
Rhinoviruses cause the majority of common colds,
which often provoke wheezing in patients with asthma.
The precise mechanisms responsible for the rhinovirus
infection-induced exacerbations of bronchial asthma
remain uncertain. However, several reports have
demonstrated airway hyperresponsiveness, increases
in chemical mediators in airway secretions, such as
kinin and histamine, and airway inflammation in
patients with bronchial asthma after rhinovirus infec-
tion. Rhinovirus infection induces the accumulation of
inflammatory cells in airway mucosa and submucosa,
including neutrophils, lymphocytes and eosinophils.
Rhinovirus affects the barrier function of airway epi-
thelial cells and activates airway epithelial cells and
other cells in the lung to produce proinflammatory
cytokines, including various types of interleukins,
granulocyte–macrophage colony stimulating factor
and RANTES, and histamine. Rhinovirus also stimu-
lates the expression of intercellular adhesion molecule-1
(ICAM-1) and low-density lipoprotein receptors in the
airway epithelium, receptors for major and minor rhi-
noviruses. Rhinovirus infection is inhibited by treatment
with soluble ICAM-1 and by the reduction of ICAM-1
expression in airway epithelial cells after treatment
with either glucocorticoid or erythromycin. Both soluble
ICAM-1 and erythromycin have been reported to
reduce the symptoms of common colds. Herein, we
review the pathogenesis and management of rhino-
virus infection-induced exacerbation of bronchial
asthma and the relationship between rhinovirus infec-
tion and airway allergy.
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C
 
LINICAL
 
 
 
IMPORTANCE
 
 
 
OF
 
 
 
RHINOVIRUS
 
 
 
INFECTION
 
 
 
ON
 
 
 
BRONCHIAL
 
 
 
ASTHMA
 
Rhinoviruses cause the majority of common colds, which
often provoke wheezing in patients with asthma.
 
1–5
 
Upper respiratory virus infections are associated with
hospital admission for asthma
 
6
 
 and the incidence of
rhinovirus infections is suggested be higher in patients
with asthma compared with control subjects.
 
7
 
 Prospec-
tive studies using cell culture techniques and detection of
increasing titers of virus-specific antibodies have indi-
cated that asthma attacks are associated with infection
by respiratory viruses, including influenza virus, adeno-
virus, respiratory syncytial viruses and rhinoviruses, in as
many as 20–50% of cases.
 
2,4
 
 Recent studies have
demonstrated that reverse transcription-polymerase
chain reaction assays are more sensitive for detecting
viruses, including rhinoviruses, compared with standard
cell culture techniques
 
5
 
 and have emphasized the impor-
tance of rhinoviruses by demonstrating that rhinoviruses
are responsible for 80–85% and 45% of the asthma
flairs in 9–11-year-old children and adults, respectively,
with rhinovirus being the most commonly implicated
pathogen.
 
1,3
 
E
 
FFECTS
 
 
 
OF
 
 
 
RHINOVIRUS
 
 
 
INFECTION
 
 
 
ON
 
 
 
HUMAN
 
 
 
SUBJECTS
 
Airway hyperresponsiveness, which is defined as the
increased sensitivity of the small airways to broncho-
constriction in response to inhaled histamine or metha-
choline, is associated with the pathogenesis of bronchial
asthma. Various studies report airway hyperresponsiveness
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after respiratory virus infections.
 
8–10
 
 Cheung 
 
et al
 
.
 
9
 
studied the effects of experimentally infected RV16 on
airway narrowing and demonstrated increased airway
hyperresponsiveness in response to inhaled metha-
choline at only 2 days after RV16 inoculation. Further-
more, the maximal response to inhaled methacholine in
the RV16-infected group was significantly higher than
that in the placebo group.
 
9
 
 Experimentally inoculated
RV16 also increases more potent airway hyper-
responsiveness to inhaled histamine in volunteers with
respiratory allergy
 
10
 
 or in asthmatic patients, including
atopic subjects,
 
11
 
 compared with non-allergic subjects.
Furthermore, rhinovirus infection increases bronchial
responsiveness to histamine and ragweed antigen in
association with increases in the histamine release from
peripheral blood leukocytes in patients with allergic
rhinitis.
 
8
 
Peak expiratory flow rate (PEFR) decreases during the
exacerbation of bronchial asthma after respiratory virus
infection, but does returns to levels seen before the infec-
tion (Fig. 1).
 
1,12
 
 In contrast, exhaled carbon monoxide,
which is suggested to be produced in the alveolar macro-
phages and airway epithelial cells in the inflamed lung,
increases in patients with untreated bronchial asthma
 
13
 
and exacerbations of bronchial asthma.
 
12
 
Infection by respiratory viruses, including rhinoviruses,
also activates histamine release from basophils in periph-
eral blood
 
14
 
 and the plasma histamine content and kinin
concentration in nasal lavage fluid increases after rhino-
virus infection.
 
15,16
 
 Rhinovirus infection causes the infiltra-
tion of neutrophils, lymphocytes and eosinophils in nasal
and bronchial mucosa.
 
11
 
 Furthermore, epithelial eosi-
nophil numbers in patients with bronchial asthma after
experimental RV16 inoculation remained elevated during
convalecence when the number of eosinophils was
similar to preinfection baseline counts in non-asthmatic
normal subjects.
 
11
 
These findings suggest that rhinovirus infection may
induce airway narrowing and airway hyperresponsive-
ness in association with airway inflammation in human
subjects, resulting in exacerbations of bronchial asthma.
Airway narrowing may be caused by inflammatory
chemical mediators released from inflammatory cells.
Similarly, inflammatory cells, including neutrophils,
lymphocytes and eosinophils may be accumulated and
activated by the inflammatory mediators and various
proinflammatory cytokines, as described below,
thereby inducing airway inflammation after rhinovirus
infections.
 
E
 
FFECTS
 
 
 
OF
 
 
 
RHINOVIRUS
 
 
 
INFECTION
 
 
 
ON
 
 
 
AIRWAY
 
 
 
EPITHELIAL
 
 
 
CELLS
 
In order to understand the mechanisms of airway inflam-
mation after rhinovirus infection, various studies have
been performed on the production of proinflammatory
substances, adhesion molecules and chemical media-
tors from cells in the lung. Rhinovirus infection increases
the production of various proinflammatory substances,
including interleukin (IL)-1
 
α
 
, IL-1
 
β
 
, IL-6, IL-8, IL-11,
tumor necrosis factor (TNF)-
 
α
 
, RANTES and granulo-
cyte–macrophage colony stimulating factor (GM-CSF) in
epithelial cells, primary cultures of epithelial cells or cell
 
Fig. 1
 
Time-course of changes in (a) exhaled carbon monox-
ide (CO) concentrations and (b) peak expiratory flow rate (PEFR)
in asthmatic patients before acute asthma exacerbations (base-
line) and after treatment with oral glucocorticoids. The arrow
indicates the start of treatment of acute asthma exacerbations
with oral glucocorticoids. Horizontal bars indicate mean values
for each time-point. Reproduced with permission from Yamaya
 
et al
 
.
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lines.
 
17–25
 
 Subauste 
 
et al
 
.
 
17
 
 demonstrated that RV14
infection induced the release of IL-6, IL-8 and TNF-
 
α
 
,
and that pre-exposure of a human bronchial epithelial
cell line (BEAS-2B) to TNF-
 
α
 
 increased susceptibility
to RV14 infection. Subauste 
 
et al
 
.
 
17
 
 suggested that
inflammatory cytokines produced by rhinovirus infection
may increase the susceptibility to rhinovirus infection.
Interleukin-6 induces antibody production in B cells and
T cell activation and differentiation. Interleukin-8 is a
major chemoattractant for neutrophils and stimulates
neutrophils to cause enzyme release and the production
of reactive oxygen species. Similarly, GM-CSF can prime
both neutrophils and eosinophils for enhanced activa-
tion to chemical stimuli. Rhinovirus infection increases
the production of eotaxin and RANTES, which activates
eosinophils, in bronchial epithelial cells.
 
18,19
 
 Interleukin-11
is suggested to have direct effects on bronchial hyper-
responsiveness.
 
24
 
 We also demonstrated that RV14, a
major rhinovirus, and RV2, a minor type of rhinovirus,
can be infected to primary culture of human tracheal
epithelial cells and submucosal gland cells through
binding to intercellular adhesion molecule (ICAM)-1 and
low-density lipoprotein (LDL) receptors, respectively,
and  produce proinflammatory cytokines, including
IL-1
 
α
 
, IL-1
 
β
 
, IL-6, IL-8, TNF-
 
α
 
 and GM-CSF, as well as
ICAM-1 and LDL receptor (Figs 2,3).
 
20–22,26
 
 Activation of
the transcription factor nuclear factor (NF)-
 
κ
 
B is associ-
ated with the production of proinflammatory cytokines
and ICAM-1,
 
23,27,28
 
 and the endogenous production of
IL-1
 
β
 
 is associated with ICAM-1 expression after rhino-
virus infection.
 
20
 
Upregulation of ICAM-1 could increase the sus-
ceptibility to major group rhinoviruses
 
29
 
 and could lead
cells adjacent to infected cells to infection when viruses
are released from the cells infected originally. Further-
more, chronic antigen challenge has been shown to
increase ICAM-1 expression on airway epithelium, which
may be related to airway inflammation in asthma.
 
30
 
Fig. 2
 
Time-course of the release of cytokines into supernatants of human tracheal submucosal gland cells after RV14 infection
(
 

 
). (
 

 
), sham infection (control). IL, interleukin; TNF-
 
α
 
, tumor necrosis factor-
 
α
 
; GM-CSF, granulocyte–macrophage colony stim-
ulating factor. Data are the mean 
 
±
 
 SEM from seven samples. *
 
P
 
 < 0.05, **
 
P
 
 < 0.01, ***
 
P
 
 < 0.001 compared with corresponding
control values. Reproduced with permission from Yamaya 
 
et al
 
.
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Inflammatory conditions, such as asthma, smoking and
ozone exposure, in which ICAM-1 expression is increased
on respiratory epithelial surfaces, may cause a pre-
disposition to rhinovirus infection by increasing the expres-
sion of the major group of rhinovirus receptors. The
rhinovirus infection would enhance airway inflammation
by recruiting neutrophils and, potentially, other inflam-
matory cells, causing increased mediator release and
exacerbation of the underlying reactive airway diseases.
Furthermore, we demonstrated that hydrogen perox-
ide increases the transepithelial influx of mannitol in
cultured human tracheal epithelial layers and rhinovirus
infection further increases the mannitol influx in cells
treated with IL-1
 
β
 
.
 
31
 
 These findings suggest that rhino-
virus infection may affect the integrity of airway epithelial
cells, although rhinovirus infection does not induce
airway epithelial cell damage,
 
32
 
 as induced by influenza
virus infection. Infection with 
 
Streptococcus pneumoniae
 
after respiratory infection is associated with the severity of
illness and more frequent hospitalization. Rhinovirus
infection also increases the adherence of 
 
S. pneumoniae
 
to human tracheal epithelial cells via increases in
platelet-activating factor receptors,
 
33
 
 suggesting that
increased adherence of 
 
S. pneumoniae
 
 may be one of
the reasons that pneumonia develops after rhinovirus
infection.
 
34
 
Fig. 3
 
(a,b) Northern blot analysis for (a) intercellular adhesion molecule (ICAM)-1 and (b) low-density lipoprotein receptor
(LDL-R) mRNA levels of human tracheal epithelial cells before (0), 8, 24, and 72 h after RV14 (a) or RV2 (b) infection in the absence
(–) or presence (+) of 10 
 
µ
 
mol/L erythromycin (EM). 
 
β
 
-Actin was used as a housekeeping gene. (c,d) Effects of 10 
 
µ
 
mol/L EM on
the expression of ICAM-1 (c) and LDL-R (d) mRNA in human tracheal epithelial cells 3 days after RV14 (c), RV2 (d) or sham (control)
infection. Both ICAM-1 and LDL-R mRNA was normalized to a constitutive expression of 
 
β
 
-actin mRNA. Data are the mean 
 
±
 
 SEM
from seven samples. Significant differences from corresponding control values are indicated by *
 
P
 
 < 0.05 and **
 
P
 
 < 0.01 com-
pared with corresponding control values; 
 
††
 
P
 
 < 0.01 compared with RV14 infection alone; 
 
†
 
P
 
 < 0.05 compared with RV2 infection
alone. To examine the effects of EM on ICAM-1 and LDL-R mRNA expression, human tracheal epithelial cells were treated with EM
or the vehicle for EM (ethanol, 0.1%) from 3 days before rhinovirus infection to the mRNA extraction after rhinovirus infection.
Reproduced with permission from Suzuki 
 
et al
 
.
 
26
 RHINOVIRUS AND BRONCHIAL ASTHMA 41
EFFECTS OF RHINOVIRUS INFECTION ON MAST 
CELLS AND CELLS OTHER THAN AIRWAY 
EPITHELIAL CELLS
Cells other than lung epithelial cells have also been
reported to produce proinflammatory substances and
chemical mediators, such as histamine. Infection of
respiratory viruses, including rhinoviruses, activates his-
tamine release from basophils of the peripheral blood14
and the plasma histamine content increases after rhino-
virus infection.16 Virus infection, including rhinovirus,
increases histamine release in basophils stimulated with
anti-IgE and calcium ionophore after rhinovirus infec-
tion.35 Furthermore, rhinovirus infection increases bron-
chial responsiveness to histamine and ragweed antigen
in association with increases in the histamine release
from peripheral blood leukocytes in patients with allergic
rhininis.8 Mast cells are major sources of histamine
release in airways and are associated with the patho-
genesis of bronchial asthma.36 We demonstrated that
rhinovirus infection primes the production of IL-4, IL-6,
IL-8, GM-CSF and histamine in response to stimuli
including IgE in both a human mast cell line and a
human basophilic leukocyte cell line (Fig. 4).37
Airway macrophages secrete TNF-α after rhinovirus
infection.38 Tumor necrosis factor-α increases the expres-
sion of ICAM-1 and other adhesion molecules on a
number of different cell types and is associated with
wheezing illness in infancy39 and the development of the
late-phase allergic reaction and asthma.40
Neutrophils accumulates in the airway during the
acute stage of a cold.41 Interleukin-8 and myeloperoxi-
dase levels in nasal aspirate increase in children during
rhinovirus infection-induced asthma exacerbations.42
Furthermore, myeloperoxidase levels in nasal aspirate
correlate with upper respiratory symptom severity.42 Thus,
IL-8 from neutrophils in the airway after rhinovirus infec-
tion may also be associated with asthma exacerbations.
Similarly, eosinophil accumulation is observed in
airway mucosa11 after experimental rhinovirus infection.
Eosinophil granular proteins, including eosinophil cati-
onic protein (ECP), have been detected in the nasal
secretions of children with wheezing illness caused by
rhinovirus infection43 and in the sputum of asthmatic
Fig. 4 (a,c) Release of hista-
mine into the supernatants of
HMC-1 cells in the presence of
(a) phorbol myristate acetate
(PMA) plus A23187, (c) IgE plus
anti-IgE (IgE + a-IgE) or vehicle
after RV14 or sham infection
(control). (b,d) Release of hista-
mine into the supernatants of
KU812 cells in the presence of
(b) PMA plus A23187, (d) IgE
plus anti-IgE (IgE + a-IgE) or
vehicle after RV14 or sham infec-
tion (control). Data are the
mean ± SEM from seven sam-
ples. **P < 0.01, ***P < 0.001
compared with RV14 infection
alone (control); ††P < 0.05,
†††P < 0.01 compared with
stimulation with PMA + A23187
or stimulation with IgE + a-IgE
alone. Reproduced with the per-
mission of The American Associ-
ation of Immunologists, Inc.,
from Hosoda et al.37
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patients infected experimentally with RV16.44 Increases in
ECP levels and the percentage of eosinophils in sputum
correlated with airway hyperresponsiveness.44 However,
RV16 did not induce superoxide production from periph-
eral blood eosinophils, as shown by Handzel et al.45
Therefore, inflammatory mediators such as RANTES and
GM-CSF18,19,21,37 released from cells, including airway
submucosal cells and mast cells, may activate eosino-
phils after rhinovirus infection. In fact, we have demon-
strated that eosinophil migration through the airway
epithelial cell layers increases in response to the addition
of supernatants of human tracheal submucosal glands
infected with RV14, through the GM-CSF and RANTES in
the supernatants.46
Rhinovirus stimulates lymphocytes to induce interferon
(IFN)-γ production and T cell proliferation through the
activation of eosinophils45 and monocytes.47 Experi-
mental rhinovirus infection revealed the accumulation of
lymphocytes and monocytes in the airway mucosa and
submucosa.11 Activated lymphocytes may also be associ-
ated with exacerbations of bronchial asthma.
Furthermore, the direct effects of rhinovirus on airway
smooth muscle contraction were demonstrated by
Hakonarson et al.48 Rhinovirus infection increased rabbit
and human airway smooth muscle constrictor responsive-
ness to acetylcholine and attenuated the dose-dependent
relaxation of the smooth muscle to β-adrenergic receptor
stimulation with isoproterenol.48
INHIBITION AND TREATMENT OF RHINOVIRUS 
INFECTION
In contrast with influenza virus, an effective vaccination
for rhinoviruses has not been developed because there
are more than 100 serotypes of rhinoviruses. A variety
of antiviral agents has been studied on the inhibition
of  rhinovirus infection or common colds, including
vitamin C,49,50 zinc gluconate lozenges,51,52 WIN com-
pounds,53,54 very low-density lipoprotein receptor frag-
ments, soluble ICAM-1,29,55,56 rhinovirus 3C protease
inhibitors,57 the compound R77975,58 IFN-α,59 dexa-
methasone,60 macrolide antibiotics bafilomycin28 and
erythromycin.26,61 However, the effect of vitamin C sup-
plementation has been controversial.50 Similarly, con-
trolled trials have revealed that zinc gluconate is not
effective52 and the nasal toxicities of INF-α may impose
some limitations for its clinical use. WIN 52084 and
R77975, antiviral agents that inhibit viral structural
dynamics,53,58 were not effective at all in reducing cold
symptoms.58 Soluble ICAM-1 inhibits the rhinovirus from
adhering to the cells29 and inhibits rhinovirus infection in
chimpanzees.55 So far, soluble ICAM-1 is the only
possible agent that may be useful in alleviating the
symptoms of the common cold.56 However, other WIN
compounds54 and a rhinovirus proteinase enzyme
inhibitor57 are undergoing phase III clinical trials. Two
viral proteases designated 2A and 3C have been viewed
as excellent targets for antiviral intervention for the
picornavirus family, including human rhinovirus.62
The specific vacuolar H+-ATPase inhibitor and macro-
lide antibiotic bafilomycin A1 blocks the infection of influ-
enza virus and rhinovirus in HeLa cells and Mardin-Darby
canine kidney (MDCK) cells63,64 and uncoating of rhino-
virus type 2 and type 14 (RV14) from late endosomes.65,66
We demonstrated the inhibitory effects of bafilomycin A1
on rhinovirus infection in human tracheal epithelial
cells.28 Bafilomycin A1 reduced the viral titer of RV14 and
inhibited the production of cytokines, including IL-1β,
IL-6, IL-8 and TNF-α, and ICAM-1 before and after RV14
infection. Bafilomycin A1 reduced the susceptibility of
epithelial cells to RV14 infection. Infection with RV14
increased activated NF-κB in the cells and bafilomycin A1
reduced the activated NF-κB. Bafilomycin A1 decreased
the number of acidic endosomes in the epithelial cells.
Furthermore, we have shown that erythromycin, a clin-
ically used macrolide antibiotic, reduces the supernatant
RV14 titer, RV14 RNA, the susceptibility to RV14 infection
and the production of ICAM-1 and cytokines (Fig. 3).26
Erythromycin also reduces the supernatant RV2 titers, RV2
RNA, the susceptibility to RV2 infection and cytokine pro-
duction, although the inhibitory effects of erythromycin on
the expression of the LDL receptor, the minor rhinovirus
receptor, were small. Erythromycin reduced NF-κB acti-
vation by RV14 and decreased the number of acidic
endosomes in epithelial cells. These results suggest that
the macrolide antibiotics erythromycin and bafilomycin
A1 inhibit infection by the major rhinovirus subgroup by
reducing ICAM-1, a receptor for a major subgroup of
rhinoviruses, and infection by both major and minor
rhinovirus subgroups by blocking the entry of rhinovirus
RNA into the endosomes in human tracheal epithelial
cells.26,28
We also showed that dexamethasone inhibits infection
by the major rhinovirus subgroup by reducing ICAM-1 in
human tracheal epithelial cells.60 Dexamethasone also
reduced the production of cytokines in epithelial cells.60
Furthermore, we showed that erythromycin therapy
has beneficial effects on the prevention of the common
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cold and exacerbations in patients with chronic
obstructive pulmonary disease (COPD).61 Low-dose and
long-term erythromycin therapy has been reported to be
effective in treating patients with diffuse panbronchiolitis
or bronchiectasis via mechanisms other than anti-
bacterial activity.67
To examine whether erythromycin therapy lowers the
frequency of the common cold and subsequent exacer-
bations in patients with COPD, a prospective, randomized,
controlled, but not blinded, trial was performed.61 One
hundred and nine patients with COPD were enrolled into
the study. Patients were assigned randomly to erythromy-
cin therapy or to no active treatment in September 1997.
Patients were then observed for 12 months, starting in
October, during which time the risk and frequency of
catching common colds and COPD exacerbations were
investigated. Fifty-five patients received erythromycin at
study entry (erythromycin group). The remaining 54
patients received no active treatment (control group). The
number of common colds for 12 months was significantly
lower in the erythromycin group than in the control
group. Similarly, the number of exacerbations for 12
months was significantly lower in the erythromycin group
than in the control group. Furthermore, significantly more
patients were hospitalized due to exacerbations in the
control group than in the erythromycin group. These find-
ings suggest that erythromycin has beneficial effects on
the prevention of common colds and exacerbations in
COPD patients. However, this intervention should be
restricted to patients who are at high risk for exacerba-
tions of COPD because of the potential risk for the emer-
gence of erythromycin-resistant pathogens.
SUMMARY OF RHINOVIRUS INFECTION-INDUCED 
AIRWAY INFLAMMATION, AIRWAY ALLERGY AND 
BRONCHIAL ASTHMA
Although the precise mechanisms remain uncertain,
various findings suggest the effects of rhinovirus infection
on the airway immune response and airway inflamma-
tion, which are associated with the exacerbations of
bronchial asthma. Rhinovirus infection affects the barrier
function of airway epithelial cells,31 whereas rhinovirus
infection has been reported not to induce epithelial
damage,32 such as epithelial detachment by influenza
virus. Rhinovirus infection also stimulates the production
of various types of proinflammatory mediators from the
airway epithelial cells, including IL-1, IL-6, IL-8, GM-
CSF and RANTES.17–25 These mediators may induce the
accumulation of inflammatory cells, such as neutrophils,
eosinophils and lymphocytes, in the airway mucosa and
submucosa11 and may activate these cells to release
reactive oxygen species and elastase,1 thereby resulting
in airway epithelial cell damage.68 Direct and indirect
airway epithelial damage and airway inflammation may
be associated with airway hypersensitivity after rhinovirus
infection.8–10
Although the role of rhinovirus infection on airway
secretion and airway smooth muscle contraction are also
uncertain, levels of kinin in nasal secretion and serum
histamine are increased after experimental rhinovirus
infection. Rhinovirus infection stimulates histamine release
from human mast cells in response to various stimuli,
including IgE,37 whereas the source of kinin remains
unknown, suggesting the association of rhinovirus infec-
tion with airway allergy. Rhinovirus infection can stimulate
the production of mucin mRNA in airway epithelial cells69
and neutrophil elastase is suggested to induce mucus
production from airway submucosal glands.70 Increased
permeability in airway epithelial cells may also be also
associated with airway hypersecretion. Rhinovirus infec-
tion directly stimulates airway smooth muscle con-
traction.48 Thus, the mucus hypersecretion, airway
contraction and airway allergy may be caused by various
mechanisms in the exacerbations of bronchial asthma
after rhinovirus infection.
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